Clinigen Group PLC (LSE:CLIN) - Share price - Overview

Stock Report

Clinigen Group PLC CLIN

Last Price
GBX967.00

Day Change
28.00|2.98%

As of 21/07/2017
17:10:26 BST | GBX
Minimum 15 Minutes Delay.

Last Close939.00p
Day Range939.50 - 969.50
Mkt Cap1.11Bil
52-Wk Range615.11 - 975.00
Yield %0.37
ISINGB00B89J2419
Volume321,805
P/E53.70
P/S3.22
P/CF25.97

Share Price

Total Returns 21/07/2017

 Chg (%)  
More ...
Clinigen Group PLC9.27 
FTSE 100 TR GBP0.14
 
Financials
201420152016
More ...
Income Statement
Turnover126.64184.40339.90
Operating Profit21.529.2020.20
Net Profit16.215.7013.50
Reported EPS19.006.3011.80
Balance Sheet
Current Assets51.43110.00112.60
Non Current Assets53.43309.10347.30
Total Assets104.86419.10459.90
Current Liabilities38.56158.40164.30
Total Liabilities38.56214.50223.40
Total Equity66.31204.60236.50
Cash Flow
Operating Cash Flow20.3415.8049.40
Net Change in Cash10.726.10-0.60
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201760.4039.74120.6924.330.204.810.50
201868.3045.0013.2421.491.625.680.59
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
28/06/2017SaleMr. John Bacon842.50200,0001,685,000.00
22/06/2017SaleMr. Peter George875.00500,0004,375,000.00
04/05/2017Transfer OutMr. Peter George0.0043,0000.00
11/11/2016SaleMr. John Bacon717.00200,0001,434,000.00

Company Profile

Clinigen Group PLC is engaged in pharmaceutical and services business. It provides its services to patients, the medical community and the healthcare industry.

Sector

Medical Distribution

Market Position

287 of 1845 Companies

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All Share

Outlook

(15/03/2017) ceo - "...well positioned to complete another year of strong growth"

Next Event 28/09/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)21.4914.6816.42
Div Yld (E)0.593.754.08
PEG (E)1.620.511.03
ROCE126.79191.3610.96
Op Mrgn7.68-4.394.34
EPS Grwth13.2436.4930.04
Dividends
PreviousLatest
More ...
Record Date04/11/1624/03/17
Ex-Div03/11/1623/03/17
Paid25/11/1613/04/17
Amnt2.701.60

Broker Sentiment

Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Peter Allen
Chief Executive OfficerShaun Chilton
Chief Financial OfficerMartin Abell
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.